FdaApplication
ANDA 209061
Identifiers
- fda_app_no: ANDA209061
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2024-09-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 600MG;200MG;300MG | TABLET;ORAL |
1 product